Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mauricio Moreno

Concepts (285)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Free Tissue Flaps
14
2025
63
7.560
Why?
Head and Neck Neoplasms
15
2025
287
6.520
Why?
Mandibular Reconstruction
3
2024
15
1.950
Why?
Neck Dissection
6
2021
30
1.820
Why?
Retrospective Studies
30
2025
6263
1.700
Why?
Length of Stay
4
2023
629
1.670
Why?
Neck
4
2021
99
1.500
Why?
Carcinoma, Squamous Cell
3
2024
326
1.480
Why?
Laryngectomy
3
2024
27
1.440
Why?
Middle Aged
35
2025
12611
1.320
Why?
Neoplasm Recurrence, Local
6
2024
629
1.310
Why?
Postoperative Complications
10
2025
1033
1.210
Why?
Aged
28
2025
9741
1.120
Why?
Salvage Therapy
2
2024
137
1.060
Why?
Aged, 80 and over
16
2025
3226
1.030
Why?
Critical Pathways
3
2023
37
0.990
Why?
Male
36
2025
25907
0.990
Why?
Female
38
2025
27081
0.970
Why?
Pharyngectomy
1
2024
2
0.920
Why?
Time-to-Treatment
2
2025
73
0.920
Why?
Skull
1
2024
75
0.900
Why?
Scalp
1
2024
40
0.900
Why?
Laryngeal Neoplasms
1
2024
43
0.890
Why?
Mandible
2
2024
28
0.880
Why?
Skin Neoplasms
4
2024
491
0.870
Why?
Humans
51
2025
50503
0.870
Why?
Operative Time
1
2023
71
0.860
Why?
Surgery, Computer-Assisted
1
2023
55
0.840
Why?
Thyroidectomy
3
2021
60
0.840
Why?
Treatment Outcome
19
2025
5283
0.820
Why?
Head
2
2021
70
0.800
Why?
Adult
24
2025
13577
0.760
Why?
Intraoperative Complications
2
2021
114
0.760
Why?
Intraoperative Care
1
2021
52
0.760
Why?
Chylothorax
1
2021
15
0.730
Why?
Hypotension
1
2021
63
0.720
Why?
Vasoconstrictor Agents
1
2021
83
0.720
Why?
Venous Thrombosis
1
2021
87
0.710
Why?
Morbidity
1
2021
130
0.700
Why?
Paranasal Sinus Neoplasms
2
2010
21
0.680
Why?
Naproxen
1
2019
7
0.670
Why?
Orthognathic Surgical Procedures
1
2019
2
0.670
Why?
Thyroid Neoplasms
2
2012
112
0.670
Why?
Reoperation
1
2021
460
0.650
Why?
Edema
1
2019
69
0.630
Why?
Health Status Indicators
1
2019
82
0.620
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2019
121
0.610
Why?
Health Resources
1
2019
74
0.600
Why?
Academic Medical Centers
2
2019
149
0.570
Why?
Radiotherapy, Adjuvant
5
2025
64
0.570
Why?
Thigh
2
2015
33
0.550
Why?
Melanoma
2
2010
280
0.540
Why?
Surgical Flaps
2
2023
114
0.520
Why?
Patient Discharge
2
2019
321
0.510
Why?
Databases, Factual
2
2019
673
0.490
Why?
Carcinoma, Papillary
2
2012
47
0.450
Why?
Parathyroidectomy
2
2012
46
0.450
Why?
Video-Assisted Surgery
1
2013
1
0.430
Why?
Tissue and Organ Harvesting
1
2013
23
0.420
Why?
Soft Tissue Injuries
1
2013
17
0.420
Why?
Neck Injuries
1
2013
21
0.420
Why?
Endoscopy
1
2013
119
0.400
Why?
Prognosis
4
2024
1978
0.390
Why?
Speech, Esophageal
1
2010
1
0.360
Why?
Graft Survival
3
2025
159
0.360
Why?
Combined Modality Therapy
3
2024
641
0.360
Why?
Palatal Obturators
1
2010
1
0.350
Why?
Parathyroid Neoplasms
1
2010
28
0.350
Why?
Neoplasm Staging
4
2024
746
0.350
Why?
Maxilla
1
2010
28
0.350
Why?
Nose Neoplasms
1
2010
3
0.350
Why?
Carcinoma, Merkel Cell
3
2016
40
0.350
Why?
Nasal Mucosa
1
2010
19
0.340
Why?
Adolescent
9
2019
6443
0.330
Why?
Preoperative Care
1
2011
169
0.330
Why?
Adenoma
1
2010
113
0.320
Why?
Follow-Up Studies
6
2023
2242
0.320
Why?
Deglutition
2
2024
43
0.300
Why?
Young Adult
7
2019
4102
0.300
Why?
Fibula
2
2024
23
0.280
Why?
Colitis, Ulcerative
2
2018
56
0.280
Why?
Crohn Disease
2
2018
93
0.270
Why?
Pain, Postoperative
3
2022
163
0.240
Why?
Osteoradionecrosis
1
2024
6
0.240
Why?
Mandibular Diseases
1
2024
11
0.240
Why?
Comorbidity
2
2019
623
0.230
Why?
TOR Serine-Threonine Kinases
2
2016
78
0.230
Why?
Adenocarcinoma
2
2023
397
0.230
Why?
Pharyngeal Diseases
1
2024
12
0.230
Why?
Cutaneous Fistula
1
2024
14
0.230
Why?
Oropharyngeal Neoplasms
1
2024
19
0.230
Why?
Physical Examination
1
2024
93
0.220
Why?
Adenoma, Pleomorphic
1
2023
3
0.220
Why?
Paranasal Sinuses
1
2023
16
0.220
Why?
Salivary Gland Neoplasms
1
2023
7
0.220
Why?
Carcinoma, Ductal
1
2023
7
0.220
Why?
Scapula
1
2023
16
0.210
Why?
Forearm
1
2023
28
0.210
Why?
Sinusitis
1
2023
41
0.210
Why?
Enteral Nutrition
1
2024
150
0.210
Why?
Deglutition Disorders
1
2024
77
0.210
Why?
Ambulatory Care Facilities
1
2023
120
0.210
Why?
Tramadol
1
2022
30
0.200
Why?
Sensitivity and Specificity
1
2024
859
0.190
Why?
Ambulatory Care
1
2023
230
0.190
Why?
Tomography, X-Ray Computed
2
2024
1164
0.190
Why?
Microsurgery
1
2021
30
0.190
Why?
Recurrent Laryngeal Nerve Injuries
1
2021
6
0.190
Why?
Anastomosis, Surgical
1
2021
66
0.190
Why?
Gastrointestinal Agents
2
2018
35
0.190
Why?
Infusions, Intravenous
1
2021
213
0.190
Why?
Indocyanine Green
2
2011
34
0.180
Why?
Drug Administration Schedule
1
2021
370
0.180
Why?
Cohort Studies
2
2019
1452
0.180
Why?
Robotics
1
2021
41
0.180
Why?
Laser Therapy
2
2011
83
0.180
Why?
Health Services Accessibility
1
2025
424
0.180
Why?
Reproducibility of Results
4
2023
1197
0.170
Why?
Odds Ratio
1
2021
551
0.170
Why?
Prospective Studies
5
2024
2378
0.170
Why?
Acetaminophen
1
2022
276
0.170
Why?
Ultrasonography
2
2012
435
0.160
Why?
Analgesics, Opioid
2
2022
575
0.160
Why?
Drug Monitoring
1
2018
79
0.150
Why?
Hospital Costs
1
2019
72
0.150
Why?
Postoperative Care
1
2019
104
0.150
Why?
Graft Rejection
1
2019
172
0.140
Why?
Arkansas
2
2025
1985
0.140
Why?
Analysis of Variance
1
2019
552
0.140
Why?
Heart Defects, Congenital
1
2023
601
0.140
Why?
Patient Readmission
1
2019
227
0.140
Why?
Antibodies, Monoclonal, Humanized
1
2018
226
0.140
Why?
Benzoxazoles
1
2016
11
0.130
Why?
United States
2
2019
4955
0.130
Why?
Predictive Value of Tests
2
2024
930
0.130
Why?
Proto-Oncogene Proteins c-myb
1
2015
8
0.120
Why?
Cell Proliferation
2
2016
985
0.120
Why?
Pyrimidines
1
2016
191
0.120
Why?
Regression Analysis
2
2012
382
0.110
Why?
Child
4
2018
6906
0.110
Why?
Nuclear Proteins
1
2015
238
0.110
Why?
Apoptosis
2
2016
1097
0.110
Why?
Skin Transplantation
1
2013
43
0.100
Why?
Quality of Life
1
2019
851
0.100
Why?
Osteocalcin
1
2012
43
0.100
Why?
Survival
1
2012
11
0.100
Why?
Equipment Design
1
2013
289
0.100
Why?
Hyperparathyroidism, Primary
1
2012
36
0.100
Why?
Recurrence
2
2012
659
0.100
Why?
Iodine Radioisotopes
1
2012
35
0.100
Why?
Leukoplakia, Oral
1
2011
6
0.100
Why?
Aminolevulinic Acid
1
2011
8
0.100
Why?
Lasers, Dye
1
2011
10
0.100
Why?
Decision Support Techniques
1
2012
70
0.100
Why?
Hospital Mortality
1
2014
413
0.100
Why?
Epigenesis, Genetic
1
2015
372
0.100
Why?
Photosensitizing Agents
1
2011
19
0.100
Why?
Thyroid Gland
2
2022
75
0.090
Why?
Dose-Response Relationship, Radiation
1
2012
183
0.090
Why?
Infrared Rays
1
2011
25
0.090
Why?
Transcription Factors
1
2015
565
0.090
Why?
Photochemotherapy
1
2011
33
0.090
Why?
Biopsy, Fine-Needle
1
2012
108
0.090
Why?
Fascia
1
2010
6
0.090
Why?
Parathyroid Hormone
1
2012
149
0.090
Why?
Lymph Node Excision
1
2012
131
0.090
Why?
Laser Coagulation
1
2011
26
0.090
Why?
Coloring Agents
1
2011
66
0.090
Why?
Tongue Neoplasms
1
2010
11
0.090
Why?
Carcinoma
1
2012
137
0.090
Why?
Kaplan-Meier Estimate
1
2012
464
0.090
Why?
Speech Intelligibility
1
2010
14
0.090
Why?
Mammary Neoplasms, Experimental
1
2011
121
0.090
Why?
Veins
1
2011
73
0.090
Why?
Survival Analysis
1
2012
661
0.090
Why?
Vascular Diseases
1
2011
73
0.080
Why?
Disease-Free Survival
1
2011
444
0.080
Why?
Lymph Nodes
1
2012
257
0.080
Why?
Tracheostomy
1
2010
71
0.080
Why?
Quality Indicators, Health Care
1
2010
87
0.080
Why?
Risk Assessment
1
2014
1270
0.080
Why?
Guideline Adherence
1
2010
136
0.080
Why?
Positron-Emission Tomography
1
2010
292
0.070
Why?
Survival Rate
1
2010
909
0.070
Why?
Models, Biological
1
2011
716
0.070
Why?
Pneumothorax, Artificial
1
2007
1
0.070
Why?
Urologic Surgical Procedures
1
2007
27
0.070
Why?
Severity of Illness Index
3
2018
978
0.070
Why?
Disease Progression
1
2010
829
0.070
Why?
Diaphragm
1
2007
31
0.070
Why?
Atrioventricular Node
1
2006
5
0.070
Why?
Tachycardia, Ectopic Atrial
1
2006
3
0.070
Why?
Cryosurgery
1
2006
36
0.060
Why?
Pilot Projects
2
2022
698
0.060
Why?
Azepines
2
2016
19
0.060
Why?
Risk Factors
1
2014
3724
0.060
Why?
Pulmonary Veins
1
2005
41
0.060
Why?
Laparoscopy
1
2007
173
0.060
Why?
Xenograft Model Antitumor Assays
2
2016
212
0.060
Why?
Triazoles
2
2016
113
0.060
Why?
Fluoroscopy
1
2024
49
0.060
Why?
Video Recording
1
2024
79
0.060
Why?
Salivary Ducts
1
2023
3
0.050
Why?
Parotid Gland
1
2023
8
0.050
Why?
Ubiquitin Thiolesterase
1
2023
17
0.050
Why?
Facial Bones
1
2023
17
0.050
Why?
Atrial Fibrillation
1
2005
188
0.050
Why?
Ibuprofen
1
2022
20
0.050
Why?
Tumor Suppressor Proteins
1
2023
128
0.050
Why?
Recurrent Laryngeal Nerve
1
2021
12
0.050
Why?
Laryngeal Nerves
1
2021
15
0.050
Why?
Glossectomy
1
2021
5
0.050
Why?
Tongue
1
2021
40
0.050
Why?
Arteries
1
2021
91
0.040
Why?
Immunohistochemistry
1
2023
957
0.040
Why?
Cell Line, Tumor
2
2015
1398
0.040
Why?
Mice
3
2016
5687
0.040
Why?
Pain Management
1
2021
180
0.040
Why?
Statistics, Nonparametric
1
2018
192
0.040
Why?
Reference Values
1
2018
307
0.040
Why?
Enzyme-Linked Immunosorbent Assay
1
2018
234
0.040
Why?
Colonoscopy
1
2018
100
0.040
Why?
Immunotherapy
1
2018
235
0.030
Why?
Chile
1
2016
4
0.030
Why?
Enterocolitis, Pseudomembranous
1
2016
24
0.030
Why?
Digestive System Surgical Procedures
1
2016
32
0.030
Why?
Age of Onset
1
2016
108
0.030
Why?
Age Distribution
1
2016
170
0.030
Why?
Mice, Inbred NOD
1
2016
91
0.030
Why?
Immunoenzyme Techniques
1
2016
137
0.030
Why?
Drug Synergism
1
2016
151
0.030
Why?
Mice, SCID
1
2016
178
0.030
Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
17
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2016
181
0.030
Why?
Tumor Cells, Cultured
1
2016
457
0.030
Why?
Enhancer Elements, Genetic
1
2015
58
0.030
Why?
Acetylation
1
2015
94
0.030
Why?
Animals
3
2016
13124
0.030
Why?
Drug Therapy, Combination
1
2016
384
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2016
572
0.030
Why?
Blotting, Western
1
2016
578
0.030
Why?
Immunosuppressive Agents
1
2016
225
0.030
Why?
Neoplasm Metastasis
1
2015
232
0.030
Why?
Chromatin
1
2015
137
0.030
Why?
Cell Cycle Proteins
1
2015
161
0.030
Why?
Referral and Consultation
1
2016
288
0.030
Why?
Amino Acid Chloromethyl Ketones
1
2013
10
0.030
Why?
Phagosomes
1
2013
19
0.030
Why?
Tissue Fixation
1
2013
34
0.030
Why?
Paraffin Embedding
1
2013
51
0.030
Why?
Formaldehyde
1
2013
49
0.030
Why?
Caspases
1
2013
103
0.030
Why?
Protein Binding
1
2015
654
0.030
Why?
Enzyme Activation
1
2013
268
0.030
Why?
Registries
1
2016
563
0.030
Why?
Promoter Regions, Genetic
1
2015
465
0.030
Why?
RNA, Messenger
1
2016
1089
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2018
1000
0.030
Why?
Preoperative Period
1
2012
48
0.020
Why?
Up-Regulation
1
2013
446
0.020
Why?
Protein Kinase Inhibitors
1
2013
204
0.020
Why?
Cell Survival
1
2013
589
0.020
Why?
Postoperative Period
1
2012
171
0.020
Why?
Administration, Topical
1
2011
57
0.020
Why?
Hospitalization
1
2016
675
0.020
Why?
Injections, Intravenous
1
2011
137
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2015
833
0.020
Why?
Multivariate Analysis
1
2012
583
0.020
Why?
Cancer Care Facilities
1
2010
18
0.020
Why?
Lasers
1
2011
106
0.020
Why?
Leg
1
2011
123
0.020
Why?
Time Factors
1
2016
2935
0.020
Why?
Biopsy
1
2011
588
0.020
Why?
Quality Assurance, Health Care
1
2010
150
0.020
Why?
Dose-Response Relationship, Drug
1
2011
1372
0.020
Why?
Child, Preschool
1
2016
3942
0.020
Why?
Carbon Dioxide
1
2007
95
0.020
Why?
Secondary Prevention
1
2006
79
0.020
Why?
Atrial Function
1
2005
7
0.020
Why?
Electrocardiography, Ambulatory
1
2005
23
0.020
Why?
Angiography
1
2005
128
0.020
Why?
Heart Rate
1
2006
307
0.010
Why?
Electrocardiography
1
2006
266
0.010
Why?
Catheter Ablation
1
2005
120
0.010
Why?
Logistic Models
1
2005
900
0.010
Why?
Moreno's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description